Good point - i incorrectly recalled a phase 2b for Fragile x had been completed. The following highlights how long it takes from phase 2 to phase 3 outcomes and potential commercialisation.
12 Nov 2014 successful phase 2a Retts; 7 Dec 20159:00am successful 2a Fragile X; 26 April 2016 - TBI with US army. While correct, this was based on a study design by the old (pre 2013 management team) and the exploratory end points introduced by current management showed superiority of the drug over placebo in the RBANS. RBANS is a validated series of tests completed by the patients for assessing cognitive impairment that is commonly used for tracking dementia. The results suggest if the trial was repeated using RBANS for efficacy, this would have been successful; and 22 Mar 2017 successful phase 2b Retts.
Hopefully we can add 2H 2021 successful Phase 3 Retts soon.
NEU Price at posting:
$1.38 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)